
Metoprolol Succinate (50mg) + Amlodipine (2.5mg)
Active composition
+1 more active ingredient
Metoprolol Succinate blocks beta-1 adrenergic receptors, leading to decreased heart rate and contractility, thereby lowering blood pressure.
Amlodipine inhibits calcium ion influx into vascular smooth muscle and cardiac muscle, leading to vasodilation and reduced myocardial oxygen demand.
Medical applications
Espin MT Tablet ER is a combination medication containing Amlodipine 2.5mg and Metoprolol Succinate 50mg, designed for the effective management of hypertension and angina pectoris. Amlodipine, a calcium channel blocker, works by relaxing blood vessels, thereby improving blood flow and reducing blood pressure. Metoprolol Succinate, a beta-1 selective beta-blocker, helps to decrease heart rate, cardiac output, and myocardial oxygen demand, which aids in controlling high blood pressure and preventing chest pain. The extended-release formulation ensures a steady release of the active ingredients, promoting consistent therapeutic effects and enhancing patient compliance by allowing once-daily dosing. Espin MT Tablet ER is particularly beneficial for patients requiring dual therapy to achieve optimal cardiovascular control. It is important to take this medication exactly as prescribed by a healthcare professional, and patients should inform their doctor about any pre-existing conditions such as asthma, diabetes, or heart block. Common side effects may include dizziness, fatigue, or swelling of the ankles. Regular monitoring of blood pressure and heart rate is recommended during treatment. Espin MT Tablet ER should not be discontinued abruptly to avoid adverse cardiovascular events.
How to use Espin MT Tablet ER Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Espin MT Tablet ER may be taken with or without food, but it is better to take it at a fixed time.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is unsafe to consume alcohol with Espin MT Tablet ER.
High Risk
Espin MT Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Espin MT Tablet ER may cause side effects which could affect your ability to drive. Espin MT Tablet ER may cause side effects such as dizziness, headaches, nausea or tiredness, all of which could affect your ability to concentrate and drive.
Exercise Caution
Espin MT Tablet ER should be used with caution in patients with liver disease. Dose adjustment of Espin MT Tablet ER may be needed. Please consult your doctor.
Regular Checkup
Espin MT Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Consult Doctor
Espin MT Tablet ER is safe to use in patients with kidney disease. No dose adjustment of Espin MT Tablet ER is recommended.
Regular Checkup
0 reviews for Espin MT Tablet ER

Amlodipine (2.5mg) + Metoprolol Succinate (50mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Metoprolol Succinate blocks beta-1 adrenergic receptors, leading to decreased heart rate and contractility, thereby lowering blood pressure.
Amlodipine inhibits calcium ion influx into vascular smooth muscle and cardiac muscle, leading to vasodilation and reduced myocardial oxygen demand.
Medical applications
Espin MT Tablet ER is a combination medication containing Amlodipine 2.5mg and Metoprolol Succinate 50mg, designed for the effective management of hypertension and angina pectoris. Amlodipine, a calcium channel blocker, works by relaxing blood vessels, thereby improving blood flow and reducing blood pressure. Metoprolol Succinate, a beta-1 selective beta-blocker, helps to decrease heart rate, cardiac output, and myocardial oxygen demand, which aids in controlling high blood pressure and preventing chest pain. The extended-release formulation ensures a steady release of the active ingredients, promoting consistent therapeutic effects and enhancing patient compliance by allowing once-daily dosing. Espin MT Tablet ER is particularly beneficial for patients requiring dual therapy to achieve optimal cardiovascular control. It is important to take this medication exactly as prescribed by a healthcare professional, and patients should inform their doctor about any pre-existing conditions such as asthma, diabetes, or heart block. Common side effects may include dizziness, fatigue, or swelling of the ankles. Regular monitoring of blood pressure and heart rate is recommended during treatment. Espin MT Tablet ER should not be discontinued abruptly to avoid adverse cardiovascular events.
How to use Espin MT Tablet ER Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Espin MT Tablet ER may be taken with or without food, but it is better to take it at a fixed time.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is unsafe to consume alcohol with Espin MT Tablet ER.
High Risk
Espin MT Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Espin MT Tablet ER may cause side effects which could affect your ability to drive. Espin MT Tablet ER may cause side effects such as dizziness, headaches, nausea or tiredness, all of which could affect your ability to concentrate and drive.
Exercise Caution
Espin MT Tablet ER should be used with caution in patients with liver disease. Dose adjustment of Espin MT Tablet ER may be needed. Please consult your doctor.
Regular Checkup
Espin MT Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Consult Doctor
Espin MT Tablet ER is safe to use in patients with kidney disease. No dose adjustment of Espin MT Tablet ER is recommended.
Regular Checkup
0 reviews for Espin MT Tablet ER















